Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/7/e011895.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849303617650032640 |
|---|---|
| author | Bi-Cheng Wang |
| author_facet | Bi-Cheng Wang |
| author_sort | Bi-Cheng Wang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-cc07db88dfff4b0b95381f13db5051aa |
| institution | Kabale University |
| issn | 2051-1426 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj-art-cc07db88dfff4b0b95381f13db5051aa2025-08-20T03:56:00ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262025-07-0113710.1136/jitc-2025-011895Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et alBi-Cheng Wang0Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Chinahttps://jitc.bmj.com/content/13/7/e011895.full |
| spellingShingle | Bi-Cheng Wang Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al Journal for ImmunoTherapy of Cancer |
| title | Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al |
| title_full | Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al |
| title_fullStr | Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al |
| title_full_unstemmed | Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al |
| title_short | Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al |
| title_sort | correspondence on pembrolizumab hybrid dosing is non inferior to flat dosing in advanced non small cell lung cancer a real world retrospective bicenter cohort study by smeenk et al |
| url | https://jitc.bmj.com/content/13/7/e011895.full |
| work_keys_str_mv | AT bichengwang correspondenceonpembrolizumabhybriddosingisnoninferiortoflatdosinginadvancednonsmallcelllungcancerarealworldretrospectivebicentercohortstudybysmeenketal |